Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Adam Eckert

SHOCKING: Why tonix pharmaceuticals stock is soaring | Mind Blowing Facts

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are trading higher Wednesday after the company announced that the United States Patent and Trademark Office issued a patent to Tonix titled, "Synthetic Chimeric Poxviruses."

The patent includes claims covering synthetic horsepox virus, the basis for the company's TNX-8011 vaccine in development to protect against monkeypox and smallpox and for the company's Recombinant Pox Virus platform to protect against other pathogens, including SARS-CoV-2.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.